Preventing persistent inflammation in the gut, lungs and skin might lower your risk of Alzheimer's disease – here's six ways ...
Nearly 7 million Americans are living with Alzheimer’s, but researchers say millions more likely have symptoms but no formal ...
Scientists have discovered an unexpected role for a protein already linked to devastating neurological diseases. The study ...
Among patients with Alzheimer's disease and elevated brain levels of both proteins, brain changes occurred up to 20 times ...
A man upset over the death of his wife kept a blanket over his head in his Minnesota nursing home. Staff gave him a powerful antipsychotic drug. Another man, in a Philadelphia facility, yelled during ...
The brain relies on real-time delivery of oxygen and nutrients through its microvasculature, which threads through neural ...
The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...
A recent study examines why Alzheimer’s presents and progresses differently in individuals using advanced biological analysis ...
The impact of neflamapimod on neurofilament light levels will be examined in a study of approximately 35 patients with ALS, facilitated by the EXPERTS-ALS platform, according to a press release from ...
The Alzheimer’s field is being turned on its head as mounting evidence points to the disease beginning outside the brain many ...
What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...
In the United States, more than 6 million individuals are living with Alzheimer’s disease, and there are about 11 million unpaid caregivers supporting them. Around the world, the disease impacts an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results